Sponsor Dossier
Alexion Pharmaceuticals
Sponsor Dossier for Alexion Pharmaceuticals. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
About
Alexion Pharmaceuticals is an Australian Private Company with ABN 59 132 343 036, registered in New South Wales. The company is currently active.
Portfolio
Alexion Pharmaceuticals has 6 brands on the ARTG, of which 6 are indexable and 6 carry a Product Information document. 3 brands are PBS-listed, 5 have a PBAC outcome on record, and 5 have an AusPAR on record. Notable brands include KANUMA, KOSELUGO, SOLIRIS, STRENSIQ, ULTOMIRIS, VOYDEYA.
Therapeutic focus
— Rare Disease: 3 brands — Haematology: 1 brand — Immunology: 1 brand — Oncology: 1 brand
PBS footprint
3 brands are PBS-listed, with the latest PBS schedule date 2026-11-01.
Regulatory activity
The latest PBAC outcome is 2025-03-01, across 5 brands with a PBAC outcome on record. The latest AusPAR is 2025-08-06, across 5 brands with an AusPAR on record.